- Library Home /
- Search Collections /
- Open Collections /
- Browse Collections /
- UBC Faculty Research and Publications /
- Incentives for valued innovation in the pharmaceutical...
Open Collections
UBC Faculty Research and Publications
Incentives for valued innovation in the pharmaceutical sector : issues for consideration by domestic and international policy makers Morgan, Steve; Greyson, Devon; Hanley, Gillian E.; Kinney, Elizabeth
Abstract
This paper provides a brief review of the economics of information and patents and an explanation of how several characteristics of the pharmaceutical market may produce suboptimal incentives for innovation. We discuss how certain pharmaceutical pricing and reimbursement policies (taken by both state and private actors) may not only be necessary for efficient pharmaceutical purchases, but may also help ensure that patents provide appropriate economic incentives for future innovation. We conclude with an examination of methods by which innovation is measured and argue that the unique characteristics of the pharmaceutical industry may justify changes in both how we measure innovation and how we reward it.
Item Metadata
Title |
Incentives for valued innovation in the pharmaceutical sector : issues for consideration by domestic and international policy makers
|
Creator | |
Contributor | |
Publisher |
Centre for Health Services and Policy Research (CHSPR)
|
Date Issued |
2006-11
|
Description |
This paper provides a brief review of the economics of information and patents and an explanation of how several characteristics of the pharmaceutical market may produce suboptimal incentives for innovation. We discuss how certain pharmaceutical pricing and reimbursement policies (taken by both state and private actors) may not only be necessary for efficient pharmaceutical purchases, but may also help ensure that patents provide appropriate economic incentives for future innovation. We conclude with an examination of methods by which innovation is measured and argue that the unique characteristics of the pharmaceutical industry may justify changes in both how we measure innovation and how we reward it.
|
Genre | |
Type | |
Language |
eng
|
Date Available |
2014-08-26
|
Provider |
Vancouver : University of British Columbia Library
|
Rights |
Attribution-NonCommercial-NoDerivs 2.5 Canada
|
DOI |
10.14288/1.0048386
|
URI | |
Affiliation | |
Peer Review Status |
Unreviewed
|
Scholarly Level |
Faculty; Researcher; Graduate
|
Rights URI | |
Aggregated Source Repository |
DSpace
|
Item Media
Item Citations and Data
Rights
Attribution-NonCommercial-NoDerivs 2.5 Canada